D. Scott Neal’s Novartis NVS Stock Holding History

D. Scott Neal’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-35	Closed	-$2K	–	174
2016 Q3	$2K	Hold	35	–	–	﹤0.01%	157
2016 Q2	$3K	Hold	35	–	–	﹤0.01%	146
2016 Q1	$2K	Hold	35	–	–	﹤0.01%	149
2015 Q4	$3K	Buy	+35	New	+$2.78K	﹤0.01%	132

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

D. Scott Neal's NVS Position: Q4 2016 in Review

D. Scott Neal sold out of Novartis (NVS) in Q4 2016, closing a stake of 35 shares — an estimated $2K sold.

D. Scott Neal first reported a position in NVS in Q4 2015 and held it in 4 quarters. The position peaked at $3K in Q2 2016. 904 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

D. Scott Neal reported no remaining Novartis position as of Q4 2016 after selling out during the quarter.
D. Scott Neal sold 35 Novartis shares in Q4 2016, an estimated $2K.
D. Scott Neal first reported a position in Novartis in Q4 2015 and held it in 4 quarters.
D. Scott Neal's Novartis position peaked at $3K in Q2 2016.
904 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on D. Scott Neal's 13F filing for Q4 2016, filed 17 Jan 2017.